Searched for
JANSSEN
Ebola outbreak sparks concern in India, US: Should you be worried? Here's what you need to know about signs, symptoms and preventionEbola in India: The WHO has declared the Ebola outbreak in Congo and Uganda a public health emergency with over 300 cases and 88 deaths. In...- Biocon Biologics gets US nod to launch Stelara biosimilarBiocon Biologics has secured USFDA approval to launch the biosimilar of Janssen's Stelara by February 2025, targeting autoimmune conditions...
- Biocon settles with Janssen to commercialise biosimilar products in Europe, Canada, JapanBiocon Biologics has entered into a settlement and licence agreement with Janssen Biotech Inc, Janssen Sciences Ireland, and Johnson & John...
- Biocon Biologics inks licence pact with Janssen for biosimilar productThe agreement licenses the company to launch in the US in February 2025, once approved by the US Food and Drug Administration(USFDA), Bioco...
- Indian Men's Hockey team faces 1-5 defeat against Netherlands in South Africa tour finaleThe Indian men's hockey team wrapped up their South Africa tour with a 1-5 defeat against the Netherlands. Despite Abhishek's lone goal, th...
- ‘Locked In’: This is what we know about British Netflix film’s cast, storyline and moreThe British Netflix film "Locked In," directed by Nour Wazzi and written by Rowan Joffé, features a cast with notable backgrounds. English ...
- J&J seeks DCGI's permission for phase-3 clinical trial of its single-dose Covid-19 vaccine“We have submitted an application to the Drugs Controller General of India (DCGI) requesting approval to conduct a bridging clinical study ...
- Johnson & Johnson arm halts R&D on Hepatitis C drugInstead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by a different virus.
- Piramal Enterprises to buy 5 Janssen drugs for Rs 1,164 croreThe transaction, which is expected to close this week, marks the Ajay Piramal-led company’s sixth deal in the healthcare space in the past ...
- Open for acquisitions especially in OTC space: Nandini Piramal, Piramal EnterprisesThe deal allow us to leverage our distribution and our marketing network in over 50 countries, said Nandini Piramal.
- Piramal to buy select injectable brands from Janssen for up to $175 millionPiramal will pay an upfront cash of $155 million and the rest on meeting certain sales-related milestones, a press release said.
- Soccer-Pochettino backs Janssen to fill Kane void for SpursSOCCER-ENGLAND-MID-TOT/POCHETTINO:Soccer-Pochettino backs Janssen to fill Kane void for Spurs
- Dishman gets licence from Johnson & Johnson to produce TB drug raw materialDishman Pharmaceuticals and Chemicals today said it has received a licence from Johnson & Johnson to manufacture raw material for a tubercu...
- Janssen India launches diabetes treatment drugTaken orally once a day, Invokana belongs to a new class of medications which work in a completely different way to other classes of type 2...
- Jubilant Biosys expands drug discovery alliance with JanssenJubilant Biosys will carry out research services and deliver preclinical candidates to Janssen for potential development and commercialisat...
- Glenmark settles patent case with Janssen for generic tabletsGlenmark Pharmaceuticals today said it has settled litigation with Janssen Pharmaceuticals Inc over patent actions regarding generic oral c...
- India needs to step up to be a biopharma major, says Boston Consulting Group"India offers several advantages in R&D, but it's behind," said Bart Janssens, a BCG partner and coauthor of the report.
- Jubilant soars on drug discovery pact with Belgian firmPharma firm Jubilant Life Sciences soared over 11% after its US-based arm inked drug discovery pact with Belgium-based Janssen Pharmaceutic...
- Aussie nod for Ranbaxy's anti-psychotic drugRanbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag's anti-schizop...
- Ranbaxy gets Australia nod for antipsychotic drugRanbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag’s anti-schizop...
Load More
